Celltrion, SK Biopharmaceuticals Drugs Poised to Top ₩1 Trillion Each Next Year — South Korea’s First Blockbusters in Sight — BigGo Finance
South Korean pharmaceutical and biotech companies are increasingly likely to produce their first global blockbuster next year —…
#EuropeSays #Korea #KR #SK #Celltrion #DaewoongPharmaceutical #HKinno.N #K-CAB #KoreaHealthIndustryDevelopmentInstitute #Nabota #NamIn-soon #SKBiopharmaceuticals #SKGroup #Xcopri #Zymfentra
https://www.europesays.com/korea/156005/